Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Catalyst Pharmaceuticals (CPRX) over the last 14 years, with Sep 2025 value amounting to $6.7 million.

  • Catalyst Pharmaceuticals' Other Working Capital Changes rose 229.64% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 120.24%. This contributed to the annual value of $11,124 for FY2024, which is 99.81% down from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Other Working Capital Changes is $6.7 million, which was down 9.59% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Other Working Capital Changes registered a high of $9.8 million during Q2 2024, and its lowest value of -$7.0 million during Q1 2025.
  • Moreover, its 3-year median value for Other Working Capital Changes was $1.7 million (2023), whereas its average is $1.9 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first spiked by 1,894.81% in 2022, then crashed by 680.17% in 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$77,000 in 2021, then spiked by 1,894.81% to $1.4 million in 2022, then tumbled by 203.26% to -$1.4 million in 2023, then spiked by 286.05% to $2.7 million in 2024, then spiked by 229.64% to $6.7 million in 2025.
  • Its Other Working Capital Changes was $6.7 million in Q3 2025, compared to $7.4 million in Q2 2025 and -$7.0 million in Q1 2025.